155 related articles for article (PubMed ID: 38115886)
1. Utility of ultrasonography in a mouse model of non-alcoholic steatohepatitis induced by a choline-deficient, high-fat diet and dextran sulfate sodium.
Hayakawa F; Soga K; Fujino J; Ota T; Yamaguchi M; Tamano M
Biochem Biophys Rep; 2023 Dec; 36():101575. PubMed ID: 38115886
[TBL] [Abstract][Full Text] [Related]
2. Utility of pemafibrate in nonalcoholic steatohepatitis model mice induced by a choline-deficient, high-fat diet and dextran sulfate sodium.
Ota T; Soga K; Hayakawa F; Yamaguchi M; Tamano M
Biochem Biophys Rep; 2024 Jul; 38():101724. PubMed ID: 38737727
[TBL] [Abstract][Full Text] [Related]
3. DSS colitis promotes tumorigenesis and fibrogenesis in a choline-deficient high-fat diet-induced NASH mouse model.
Achiwa K; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Hayashi K; Hirooka Y; Katano Y; Goto H
Biochem Biophys Res Commun; 2016 Jan; 470(1):15-21. PubMed ID: 26682925
[TBL] [Abstract][Full Text] [Related]
4. Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice.
Honda T; Ishigami M; Luo F; Lingyun M; Ishizu Y; Kuzuya T; Hayashi K; Nakano I; Ishikawa T; Feng GG; Katano Y; Kohama T; Kitaura Y; Shimomura Y; Goto H; Hirooka Y
Metabolism; 2017 Apr; 69():177-187. PubMed ID: 28285648
[TBL] [Abstract][Full Text] [Related]
5. Raloxifene Ameliorates Liver Fibrosis of Nonalcoholic Steatohepatitis Induced by Choline-Deficient High-Fat Diet in Ovariectomized Mice.
Luo F; Ishigami M; Achiwa K; Ishizu Y; Kuzuya T; Honda T; Hayashi K; Ishikawa T; Katano Y; Goto H
Dig Dis Sci; 2015 Sep; 60(9):2730-9. PubMed ID: 25868633
[TBL] [Abstract][Full Text] [Related]
6. A Novel Animal Model of Nonalcoholic Steatohepatitis (NASH): Hypoxemia Enhances the Development of NASH.
Takayama F; Egashira T; Kawasaki H; Mankura M; Nakamoto K; Okada S; Mori A
J Clin Biochem Nutr; 2009 Nov; 45(3):335-40. PubMed ID: 19902025
[TBL] [Abstract][Full Text] [Related]
7. Microbiome, fibrosis and tumor networks in a non-alcoholic steatohepatitis model of a choline-deficient high-fat diet using diethylnitrosamine.
Yamamoto K; Honda T; Yokoyama S; Ma L; Kato A; Ito T; Ishizu Y; Kuzuya T; Nakamura M; Kawashima H; Ishigami M; Tsuji NM; Fujishiro M
Dig Liver Dis; 2021 Nov; 53(11):1443-1450. PubMed ID: 33726979
[TBL] [Abstract][Full Text] [Related]
8. Antifibrotic Effects of 1,25(OH)
Ma L; Ishigami M; Honda T; Yokoyama S; Yamamoto K; Ishizu Y; Kuzuya T; Hayashi K; Hirooka Y; Goto H
Dig Dis Sci; 2019 Sep; 64(9):2581-2590. PubMed ID: 30825110
[TBL] [Abstract][Full Text] [Related]
9. Astaxanthin Attenuates Nonalcoholic Steatohepatitis with Downregulation of Osteoprotegerin in Ovariectomized Mice Fed Choline-Deficient High-Fat Diet.
Zhao M; Ma L; Honda T; Kato A; Ohshiro T; Yokoyama S; Yamamoto K; Ito T; Imai N; Ishizu Y; Nakamura M; Kawashima H; Tsuji NM; Ishigami M; Fujishiro M
Dig Dis Sci; 2023 Jan; 68(1):155-163. PubMed ID: 35397697
[TBL] [Abstract][Full Text] [Related]
10. Premorbid Steatohepatitis Increases the Seriousness of Dextran Sulfate Sodium-induced Ulcerative Colitis in Mice.
Wang MY; Wang ZX; Huang LJ; Yang RX; Zou ZY; Ge WS; Ren TY; Fan JG
J Clin Transl Hepatol; 2022 Oct; 10(5):847-859. PubMed ID: 36304494
[TBL] [Abstract][Full Text] [Related]
11. Dextran Sulfate Sodium Salt-Induced Colitis Aggravates Gut Microbiota Dysbiosis and Liver Injury in Mice With Non-alcoholic Steatohepatitis.
Shen B; Wang J; Guo Y; Gu T; Shen Z; Zhou C; Li B; Xu X; Li F; Zhang Q; Cai X; Dong H; Lu L
Front Microbiol; 2021; 12():756299. PubMed ID: 34795650
[No Abstract] [Full Text] [Related]
12. High-fat diet combined with dextran sulfate sodium failed to induce a more serious NASH phenotype than high-fat diet alone.
Zhou Y; Feng Y; Yang L; Zheng P; Hang L; Jiang F; Yuan J; Zhu L
Front Pharmacol; 2022; 13():1022172. PubMed ID: 36238563
[No Abstract] [Full Text] [Related]
13. DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH.
Gäbele E; Dostert K; Hofmann C; Wiest R; Schölmerich J; Hellerbrand C; Obermeier F
J Hepatol; 2011 Dec; 55(6):1391-9. PubMed ID: 21703208
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic steatohepatitis-associated hepatocarcinogenesis in mice fed a modified choline-deficient, methionine-lowered, L-amino acid-defined diet and the role of signal changes.
Suzuki-Kemuriyama N; Abe A; Nakane S; Yuki M; Miyajima K; Nakae D
PLoS One; 2023; 18(8):e0287657. PubMed ID: 37535625
[TBL] [Abstract][Full Text] [Related]
15. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis.
Matsumoto M; Hada N; Sakamaki Y; Uno A; Shiga T; Tanaka C; Ito T; Katsume A; Sudoh M
Int J Exp Pathol; 2013 Apr; 94(2):93-103. PubMed ID: 23305254
[TBL] [Abstract][Full Text] [Related]
16. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.
Wei G; An P; Vaid KA; Nasser I; Huang P; Tan L; Zhao S; Schuppan D; Popov YV
Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G174-G188. PubMed ID: 31630534
[TBL] [Abstract][Full Text] [Related]
17. Effects of docosahexaenoic acid in an experimental rat model of nonalcoholic steatohepatitis.
Takayama F; Nakamoto K; Totani N; Yamanushi T; Kabuto H; Kaneyuki T; Mankura M
J Oleo Sci; 2010; 59(8):407-14. PubMed ID: 20625232
[TBL] [Abstract][Full Text] [Related]
18. Severe steatosis and mild colitis are important for the early occurrence of hepatocellular carcinoma.
Sato T; Tsuchiya A; Owaki T; Kumagai M; Motegi S; Iwasawa T; Nojiri S; Ogawa M; Takeuchi S; Watanabe Y; Kawata Y; Kamimura H; Terai S
Biochem Biophys Res Commun; 2021 Aug; 566():36-44. PubMed ID: 34116355
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet.
Ikawa-Yoshida A; Matsuo S; Kato A; Ohmori Y; Higashida A; Kaneko E; Matsumoto M
Int J Exp Pathol; 2017 Aug; 98(4):221-233. PubMed ID: 28895242
[TBL] [Abstract][Full Text] [Related]
20. Activated Natural Killer Cell Promotes Nonalcoholic Steatohepatitis Through Mediating JAK/STAT Pathway.
Wang F; Zhang X; Liu W; Zhou Y; Wei W; Liu D; Wong CC; Sung JJY; Yu J
Cell Mol Gastroenterol Hepatol; 2022; 13(1):257-274. PubMed ID: 34506952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
